Search for media from: "Bharathi Vennapusa"

Assay Implementation: IHC Assays

Short video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071

From  Bharathi Vennapusa 0 likes 4 plays

CAP/ASCO HER2 2018 Guideline update and RocheHER2 Assays

Dr. Bharathi Vennapusa from Roche MSA discusses 2018 CAP/ASCO HER2 guideline update and how it pertains to Roche HER2 Assays. Content and approvals of any product related information is current as of…

From  Bharathi Vennapusa 0 likes 8 plays

Case Study: Assessing PD-L1 in TNBC - Scoring cases with common staining patterns

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in the triple negative breast…

From  Bharathi Vennapusa 0 likes 4 plays

Case Study: Assessing PD-L1 in TNBC - Select cases with staining near the scoring algorithm cut-off

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a pathologist will see in the…

From  Bharathi Vennapusa 0 likes 5 plays

Case Study: Assessing PD-L1 in TNBC. Moderate IC staining without TC staining

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the triple negative breast cancer…

From  Bharathi Vennapusa 0 likes 7 plays

Down the Ocular Episode # 2 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 1

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the PD-L1 (SP142) assay in non-small cell lung cancer. Drs.…

From  Bharathi Vennapusa 0 likes 6 plays

Down the Ocular Episode # 3 - VENTANA PD-L1 (SP142) Assay in NSCLC Part 2

This episode is part 2 in a series on the PD-L1 (SP142) assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD…

From  Bharathi Vennapusa 0 likes 3 plays

Down the Ocular episode 4 - CAP_ASCO 2018 guidelines and Roche HER2 assays

This is episode 4 of the Down the Ocular podcast. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the 2018…

From  Bharathi Vennapusa 0 likes 5 plays

Down the Ocular Episode-1-NTRK overview, testing methods and algorithms and pan-TRK IHC assay

Down the Ocular Episode # 2: VENTANA pan-TRK (EPR17341) Assay: This episode focuses on the NTRK fusions; their detection, the testing methodologies used, and their role in solid tumors. Dr. Bharathi…

From  Bharathi Vennapusa 0 likes 26 plays

Down the Ocular Pilot Episode - Remote Digital Pathology Devices - Guidance during COVID-19 Pandemic

In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the use of digital pathology devices during the COVID-19…

From  Bharathi Vennapusa 0 likes 2 plays

ER/PgR Testing in Breast Cancer: CAP/ASCO 2020 Guideline update

Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.

From  Bharathi Vennapusa 0 likes 4 plays

Every Slide Tells a Story: Methods for Successful Immunohistochemical Staining

Review of preanalytic variables in immunohistochemical assay staining. TE-US-01089

From  Bharathi Vennapusa 0 likes 4 plays

FDA classifications & Development of In Vitro Diagnostic Assays

Review of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092

From  Bharathi Vennapusa 0 likes 8 plays

How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma

US Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma cases. Common questions are addressed and…

From  Bharathi Vennapusa 0 likes 6 plays

Interpretation of VENTANA pan-TRK (EPR17341) Assay - digital case review

Dr. Bharathi Vennapusa from Roche MSA reviews example cases stained with VENTANA pan-TRK (EPR17341) Assay using digital slides. Content and approvals of any product related info is current as of the…

From  Bharathi Vennapusa 0 likes 19 plays

Low Prevalence Biomarkers: Validation Approach

Validation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072

From  Bharathi Vennapusa 0 likes 4 plays